Protocol No.: NRG-GY018

Title
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Principal Investigator
Galvan Turner, Valerie
Phase
III
Age Group
Adult
Applicable Disease Site
Gynecologic Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Deborah Moore, MS
Research Specialist
Phone: +1 304-293-0609

View on ClinicalTrials.gov